Joseph Pitts said...
Do you believe that we need to further incentivize new drug and diagnostic development if we are to appropriately address the issue of antibiotic resistance, and if so, what would you recommend?
Context
Pitts questions the need for incentives in drug development for antibiotic resistance.
09/18/2014